VTR
72
2
KR
55
2
CCI
38
2
RF
50
2
EXC
53
2
PH
69
2
WMB
67
3
EMR
39
2
APH
73
2
AAP
33
4
LRCX
59
6
FRT
58
-5
RRC
68
3
DFS
62
3
EIX
58
2
AVGO
42
2
DNB
36
4
WY
39
3
LLY
60
-7
CRM
49
2
VTR
72
2
KR
55
2
CCI
38
2
RF
50
2
EXC
53
2
PH
69
2
WMB
67
3
EMR
39
2
APH
73
2
AAP
33
4
LRCX
59
6
FRT
58
-5
RRC
68
3
DFS
62
3
EIX
58
2
AVGO
42
2
DNB
36
4
WY
39
3
LLY
60
-7
CRM
49
2
Financhill
Back

GT Biopharma Stock Price Chart

Elon's Secret "A.I. 2.0" Project

Click here now to discover how to claim a stake in Elon's "A.I. 2.0" project
Sell
17

GTBP
GT Biopharma

Last Price:
3.30
Seasonality Move:
2.37%

7 Day Trial

ALL ACCESS PASS

$ 7

America's Final Republican President

Click here to see his 2024 election prediction.
  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GTBP is experiencing selling pressure, which indicates risk of future bearish movement.

GT Biopharma Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 3.31 Sell
20-day SMA: 3.65 Sell
50-day SMA: 4.09 Sell
200-day SMA: 6.44 Sell
8-day EMA: 3.32 Sell
20-day EMA: 3.61 Sell
50-day EMA: 4.14 Sell
200-day EMA: 8.79 Sell

GT Biopharma Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.29 Sell
Relative Strength Index (14 RSI): 38.89 Sell
Chaikin Money Flow: -2857 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.37 - 4.21) Sell
Bollinger Bands (100): (3.73 - 6.71) Sell

GT Biopharma Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for GT Biopharma Stock

Is GT Biopharma Stock a Buy?

  • GT Biopharma share price is 3.30 while GTBP 8-day simple moving average is 3.31, which is a Sell signal.
  • The stock price of GTBP is 3.30 while GT Biopharma 20-day SMA is 3.65, which makes it a Sell.
  • GT Biopharma 50-day simple moving average is 4.09 while GTBP share price is 3.30, making it a Sell technically.
  • GTBP stock price is 3.30 and GT Biopharma 200-day simple moving average is 6.44, creating a Sell signal.

GTBP Technical Analysis vs Fundamental Analysis

Sell
17
GT Biopharma (GTBP) is a Sell

Is GT Biopharma a Buy or a Sell?

  • GT Biopharma stock is rated a Sell
    The current GT Biopharma [GTBP] share price is $3.30. The Score for GTBP is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.

GT Biopharma Stock Info

Market Cap:
4.56M
Price in USD:
3.30
Share Volume:
2.86K

GT Biopharma 52-Week Range

52-Week High:
16.11
52-Week Low:
2.95
Sell
17
GT Biopharma (GTBP) is a Sell

GT Biopharma Share Price Forecast

  • What is the GT Biopharma stock price today?
    The GT Biopharma stock price is 3.30 USD today.
  • Will GTBP stock go up or go down?
    GT Biopharma> share price is forecast to RISE/FALL based on technical indicators
  • Is GT Biopharma overvalued?
    According to simple moving average, exponential moving average, oscillators, and other technical indicators, GT Biopharma is overvalued.

Is GT Biopharma Stock a Buy?

  • GT Biopharma share price is 3.30 while GTBP 8-day exponential moving average is 3.32, which is a Sell signal.
  • The stock price of GTBP is 3.30 while GT Biopharma 20-day EMA is 3.61, which makes it a Sell.
  • GT Biopharma 50-day exponential moving average is 4.14 while GTBP share price is 3.30, making it a Sell technically.
  • GTBP stock price is 3.30 and GT Biopharma 200-day simple moving average is 8.79, creating a Sell signal.

Fundamental Analysis of GT Biopharma

Is GT Biopharma a good investment?

  • Analysts estimate an earnings decrease this quarter of $3.21 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.43 per share, and a decrease next year of $0.00 per share.

Technical Analysis of GT Biopharma

Should I short GT Biopharma stock?

* GT Biopharma stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.